Rituxan (rituximab) - Roche
A public-data audit of transcriptomic prognostic transportability in R-CHOP-treated diffuse large B-cell lymphoma. (PubMed, PLoS One) - Oct 25, 2026 - "Public DLBCL transcriptomic associations can be cohort-specific despite fixed scoring rules. Independent full-coverage evaluation and transparent treatment and platform audits should precede claims of general prognostic utility." 
Biomarker • Journal • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Oncology
http://www.ncbi.nlm.nih.gov/pubmed/42912792
 
Guowei Xiong; Haoyun Hong; Lin Lin; Qi Chen; Wenhao Feng; Yingying Qin; Yongqing Li
 
Oct 25, 2026
 
Prev Next